Skip to main content
Premium Trial:

Request an Annual Quote

Marshfield to Evaluate PathoGenetix System for Food Pathogen Testing

NEW YORK (GenomeWeb News) – PathoGenetix today said that Marshfield Food Safety will evaluate and provide feedback on PathoGenetix's Resolution Microbial Genotyping System.

The system uses PathoGenetix's Genome Sequence Scanning technology to identify molecular serotype and strain type information on foodborne pathogens. It analyzes microbial DNA directly from enriched food samples and can type target bacteria in just five hours, even when multiple serovars are present, the Woburn, Mass.-based firm said.

Unlike, pulsed field gel electrophoresis , which currently is the current gold standard for pathogen identification, GSS is culture independent and fully automated from sample preparation to final report, said PathoGenetix.

Marshfield will conduct testing of the Resolution instrument, assays, and database in its own laboratory, and will provide feedback to PathoGenetix on the speed, utility, and ease-of-use of the system for food safety applications. Terms of the agreement were not disclosed.

"We believe the system can simplify pathogen confirmation and reduce the time required to identify microbial contamination and trace it back to the original source in the production facility," Marshfield CEO Roy Radcliff said in a statement.

Earlier this year PathoGenetix said in separate announcements that both the US Food and Drug Administration and the US Department of Agriculture's Agricultural Research Service were evaluating its technology.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.